A 12-week prospective cohort enrolled 73 patients with guideline-based asthma or COPD and no speech-affecting comorbidities, ...

Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the second quarter of 2026 ...

The U.S. Chronic Obstructive Pulmonary Disease Market is projected to grow from USD 6.93 Billion in 2025 to USD 10.93 Billion ...

The American Lung Association is announcing a new initiative to help people living with chronic obstructive pulmonary disease ...

Complementary MESA analyses validate AI-derived chamber volumetry from non-gated, non-contrast CT for heart failure and ...

Cognitive impairment, manual dexterity, and suboptimal peak inspiratory flow are associated with inadequate inhaler technique and poor outcomes in patients with chronic obstructive pulmonary disease ...

BLVR has shown potential for restoring lung function and improving quality of life among individuals with chronic obstructive pulmonary disease (COPD), who have few other options for treatment, said ...

Canadian wildfire smoke is expected to continue blanketing Massachusetts on Thursday, state officials reported, with air ...

Lawmakers unveiled a bipartisan bill to invest VA funds into diagnostic scanning software that could detect asthma or lung ...

Coloradans are increasingly concerned about their ability to stay in the state as they make trade-offs and express ...

The Pentagon's new testosterone screening policy will test troops over 30. A doctor explains what the research shows about ...

I want to thank you for joining NAVREF for today's discussion on the future of lung cancer screening for veterans. My name is Rashi Romanoff. I am the CEO of the National Association for Veterans ...